These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6656169)
1. [Advantages of hyposensitization with a high dose of allergoid in pollen allergy]. Kuhn W; Urbanek R; Forster J; Schreyer H; Wais U Klin Padiatr; 1983; 195(6):411-4. PubMed ID: 6656169 [TBL] [Abstract][Full Text] [Related]
2. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
3. [Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid]. Mühlethaler K; Wüthrich B; Peeters AG; Terki N; Girard JP; Frank E Schweiz Rundsch Med Prax; 1990 Apr; 79(14):430-6. PubMed ID: 2188335 [TBL] [Abstract][Full Text] [Related]
4. [New possibilities of hyposensitization with pollen-l-tyrosine complexes (author's transl)]. Horak F Laryngol Rhinol Otol (Stuttg); 1978 Nov; 57(11):961-5. PubMed ID: 723401 [TBL] [Abstract][Full Text] [Related]
5. [Immunological and clinical studies on the pollen-L-tyrosin complexes in hyposensitization therapy]. Horak F Wien Med Wochenschr; 1977 Nov; 127(22):677-81. PubMed ID: 595610 [No Abstract] [Full Text] [Related]
6. [Hyposensitization with cross-reacting pollen allergens]. Karl S; Rakoski J Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627 [TBL] [Abstract][Full Text] [Related]
7. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children. Wahn U; Maasch HJ; Geissler W Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730 [TBL] [Abstract][Full Text] [Related]
8. [How and when is immunotherapy for pollen allergy carried out?]. Kersten W Med Klin; 1980 Oct; 75(21):751-4. PubMed ID: 7453622 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [TBL] [Abstract][Full Text] [Related]
10. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis. Williams A; Henzgen M; Rajakulasingam K Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually. Panzner P; Petrás M; Sýkora T; Lesná I Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908 [TBL] [Abstract][Full Text] [Related]
12. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U; Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data. Ariano R; Panzani RC; Mistrello G Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis. Tari MG; Mancino M; Pozzuoli G; Mauro B; Verga A; Monti G Allergol Immunopathol (Madr); 1990; 18(1):35-40. PubMed ID: 2382596 [TBL] [Abstract][Full Text] [Related]
15. [Allergen immunotherapy with an immunochemically characterized grass pollen extract: change in follow-up sensitization parameters]. Collet M; Urbanek R Klin Padiatr; 1989; 201(3):183-8. PubMed ID: 2739344 [TBL] [Abstract][Full Text] [Related]
16. [A modified therapy of hayfever with a depot-preparation (author's transl)]. Skoda-Türk R; Horak F; Jäger S Wien Klin Wochenschr Suppl; 1980; 117():24-6. PubMed ID: 6936978 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368 [TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
19. [IgE and IgG antibody response in patients with type I allergy to birch pollen]. Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]